What are the possible etiologies of a left ventricular ejection fraction of 10%?

Etiologies of Left Ventricular Ejection Fraction of 10%

An ejection fraction of 10% represents severe left ventricular systolic dysfunction and is most commonly caused by ischemic cardiomyopathy (coronary artery disease with prior myocardial infarction) or dilated cardiomyopathy from non-ischemic causes. 1

Primary Etiologic Categories

The fundamental distinction in heart failure with severely reduced ejection fraction (HFrEF) is between ischemic versus non-ischemic cardiomyopathy 1. This classification drives both diagnostic workup and therapeutic decisions.

Ischemic Cardiomyopathy

• Chronic coronary artery disease with prior myocardial infarction
• Represents the most common etiology in many populations 2
• Results from permanent myocardial damage or chronically hibernating myocardium 3

Non-Ischemic Dilated Cardiomyopathy

Specific causes include:

• Idiopathic dilated cardiomyopathy - diagnosis of exclusion when no cause identified
• Hypertensive heart disease - chronic uncontrolled hypertension leading to progressive ventricular dysfunction 1
• Valvular heart disease - particularly severe aortic stenosis, aortic regurgitation, or mitral regurgitation causing chronic volume/pressure overload 4, 5
• Toxic cardiomyopathy:
  • Alcohol-induced
  • Chemotherapy-related (anthracyclines, trastuzumab, tyrosine kinase inhibitors) 6
• Myocarditis - viral, autoimmune, or other inflammatory causes 1
• Peripartum cardiomyopathy - develops in late pregnancy or early postpartum 6
• Takotsubo cardiomyopathy - though typically reversible, can present with severely reduced EF 6
• Infiltrative diseases - amyloidosis, sarcoidosis, hemochromatosis
• Genetic/familial cardiomyopathies
• Tachycardia-induced cardiomyopathy - from sustained rapid heart rates
• Nutritional deficiencies - thiamine, selenium
• Endocrine disorders - thyroid disease, pheochromocytoma

Critical Diagnostic Considerations

Immediate Assessment Priorities

When encountering EF of 10%, focus on:

1. Ischemic vs. non-ischemic differentiation - This is the most clinically relevant distinction 1

   • History of coronary disease, prior MI, or angina
   • Coronary angiography or non-invasive stress testing
   • Regional wall motion abnormalities on echo suggest ischemic etiology 7

2. Reversible causes:

   • Acute myocarditis
   • Tachycardia-induced cardiomyopathy
   • Severe valvular disease amenable to intervention
   • Toxic exposures (alcohol, chemotherapy)
   • Thyroid dysfunction

3. Structural abnormalities:

   • Severe valvular regurgitation or stenosis 4, 5
   • Left ventricular dimensions and volumes 8
   • Right ventricular function 8

Prognostic Context

An EF of 10% carries extremely high mortality risk - approximately 50% mortality within 5 years of heart failure diagnosis 1, with even higher rates at such severely reduced function 9. However, once EF falls below 20%, the absolute EF value becomes less predictive of mortality 9. At this severity level, peak VO2 (functional capacity) becomes a stronger predictor of outcomes than the specific EF measurement 9.

Important Caveats

• EF measurement has poor reproducibility, particularly at extreme values 10
• The trajectory of EF (improving vs. stable vs. declining) may be more clinically relevant than a single measurement 10
• Approximately 15% of patients admitted with severely reduced EF may show improvement to >40% during hospitalization (HFimpEF), which carries better prognosis 11
• Predictors of EF improvement include valvular etiology, absence of right ventricular dysfunction, and less severe left ventricular remodeling 11

Clinical Approach Algorithm

1. Confirm severe systolic dysfunction with comprehensive echocardiography including chamber dimensions, wall motion, and valvular assessment 8

2. Determine ischemic vs. non-ischemic etiology:

   • If known CAD or regional wall motion abnormalities → likely ischemic
   • If global dysfunction without CAD history → pursue non-ischemic workup

3. Evaluate for reversible causes:

   • Recent viral illness, alcohol use, chemotherapy exposure
   • Thyroid function tests
   • Sustained tachyarrhythmias on telemetry

4. Assess for structural disease:

   • Severe valvular pathology requiring intervention
   • Infiltrative disease if clinical suspicion (cardiac MRI may be needed)

5. Risk stratify beyond EF:

   • Functional capacity assessment
   • Natriuretic peptide levels
   • Right ventricular function
   • Renal function and other comorbidities

The etiology determination is critical because it guides specific interventions (revascularization for ischemic disease, valve surgery for valvular disease, immunosuppression for myocarditis, etc.) beyond standard guideline-directed medical therapy for HFrEF 12, 13.